Neurology Drugs Research
6 comprehensive market analysis studies and research reports on the Neurology Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 81 companies, enriched with industry statistics, insights, and a lot more.
Healthcare
Categories
6 Healthcare Reports
Categories
Filters and Sort
Showing 6 of 6 results in Neurology Drugs
Migraine Therapeutics Market
CAGR: 6.75%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:Amgen, Teva Pharmaceutical Industries, GlaxoSmithKline, Eli Lilly and Company, Bausch Health
Tourette Syndrome Treatment Market
CAGR: 5.06%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:AstraZeneca, Reviva Pharmaceuticals, Viatris, Otsuka, Teva Pharmaceutical Industries
Frontotemporal Disorders Treatment Market
CAGR: 4.81%
Study Period: 2022 - 2031
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Teva Pharmaceutical Industries, Pfizer, AstraZeneca, Biogen, Lundbeck A/S
Global Amyotrophic Lateral Sclerosis Treatment Market
CAGR: 5.86%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Mitsubishi Tanabe Pharma, CORESTEM, BrainStorm Cell, Amylyx Pharmaceuticals, Biogen
Head And Neck Cancer Therapeutics Market
CAGR: 11.92%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia Pacific, South America, Middle East and Africa
Major Players:Eli Lilly and Company, Sanofi, Merck, Clinigen, Bristol-Myers Squibb
Epilepsy Drugs Market
CAGR: 4.5%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Jazz Pharmaceuticals, Novartis, Pfizer, SK Biopharmaceuticals Co. Ltd., UCB
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
